Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Fatima Karzai(National Institutes of Health), William L. Dahut(National Cancer Institute), Akira Yuno(National Institutes of Health), Ryan Dittamore(Epic Sciences (United States)), Paul S. Meltzer(National Cancer Institute), Maria J. Merino(National Institutes of Health), Jennifer L. Marté(National Cancer Institute), Lisa M. Cordes(National Institutes of Health Clinical Center), Jane B. Trepel(National Institutes of Health), Amy Hankin(National Institutes of Health), Seth M. Steinberg(National Institutes of Health), Ravi A. Madan(National Cancer Institute), Marijo Bilušić(National Institutes of Health), Renee N. Donahue(National Institutes of Health), Kathleen Kelly(National Cancer Institute), Jeffrey Schlom(National Cancer Institute), Keith Killian(National Institutes of Health), Venkatesh Krishnasamy(National Institutes of Health), James L. Gulley(National Cancer Institute), David James VanderWeele(Northwestern University), Anna Couvillon(National Institutes of Health), Jung Min Lee(National Institutes of Health), Sunmin Lee(National Institutes of Health), Helen Owens(National Institutes of Health), E. Hitt Nichols(Leidos (United States)), Min-Jung Lee(National Institutes of Health), Michael L. Beshiri(National Cancer Institute)
Cited by 312
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Targeting the dynamic HSP90 complex in cancer
|Nature reviews. Cancer|2010|1.5k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|973
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
|Blood|2005|896
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817